CYTO NK-203 / CytoImmune, City of Hope - LARVOL DELTA

City of Hope researchers will present new treatments for blood, prostate and other cancers at 2023 American Society of Clinical Oncology Annual Meeting (PRNewswire) - "The team found that the PSCA-CAR T cell therapy had anti-cancer effects in these patients and more so in patients who had also received lymphodepletion (LD) chemotherapy. They also found that a lower dose of LD chemotherapy lessened the toxicity, or harmful effects, of the treatment without clear negative impact on CAR T expansion....To further test the approach, the team will open a Phase 1b clinical trial with a new dosing strategy soon, which they believe will achieve greater efficacy with lower toxicity."

P1 data • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor